Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Hommes

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Current Drug Targets|March 10, 2010
Anti-TNF and Crohn's disease: when should we start?H H Fidder, D W Hommes
Cytokine|December 14, 2004
New cytokine therapeutics for inflammatory bowel diseaseP C F Stokkers, D W Hommes
Current Opinion in Clinical Nutrition and Metabolic Care|June 28, 2000
Anti- and proinflammatory cytokines in the pathogenesis of tissue damage in Crohn's diseaseD W Hommes, S J van Deventer
The Netherlands Journal of Medicine|July 11, 2003
Infliximab therapy in Crohn's disease: safety issuesD W Hommes, S J H van Deventer
Expert Opinion on Biological Therapy|March 23, 2017
Autologous hematopoietic stem cells for refractory Crohn's diseaseC A DiNicola, A Zand, D W Hommes
Journal of Crohn'S & Colitis|December 22, 2010
Stem cells as potential novel therapeutic strategy for inflammatory bowel diseaseM Duijvestein, G R van den Brink, D W Hommes
Gut|December 13, 2002
Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targetsD W Hommes, M P Peppelenbosch, S J H van Deventer
The Cochrane Database of Systematic Reviews|October 19, 2007
Fish oil for induction of remission in ulcerative colitisM De Ley, R de Vos, D W Hommes, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 26, 2005
[Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis]R C Minnee, P Stokkers, S C Riemens, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2006
Review article: thiopurines in inflammatory bowel diseaseL J J Derijks, L P L Gilissen, P M Hooymans, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Current Drug Targets|March 10, 2010
Anti-TNF and Crohn's disease: when should we start?H H Fidder, D W Hommes
Cytokine|December 14, 2004
New cytokine therapeutics for inflammatory bowel diseaseP C F Stokkers, D W Hommes
Current Opinion in Clinical Nutrition and Metabolic Care|June 28, 2000
Anti- and proinflammatory cytokines in the pathogenesis of tissue damage in Crohn's diseaseD W Hommes, S J van Deventer
The Netherlands Journal of Medicine|July 11, 2003
Infliximab therapy in Crohn's disease: safety issuesD W Hommes, S J H van Deventer
Expert Opinion on Biological Therapy|March 23, 2017
Autologous hematopoietic stem cells for refractory Crohn's diseaseC A DiNicola, A Zand, D W Hommes
Journal of Crohn'S & Colitis|December 22, 2010
Stem cells as potential novel therapeutic strategy for inflammatory bowel diseaseM Duijvestein, G R van den Brink, D W Hommes
Gut|December 13, 2002
Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targetsD W Hommes, M P Peppelenbosch, S J H van Deventer
The Cochrane Database of Systematic Reviews|October 19, 2007
Fish oil for induction of remission in ulcerative colitisM De Ley, R de Vos, D W Hommes, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 26, 2005
[Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis]R C Minnee, P Stokkers, S C Riemens, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2006
Review article: thiopurines in inflammatory bowel diseaseL J J Derijks, L P L Gilissen, P M Hooymans, et al.
Pageof 6